• letlifehappen's Avatar

    letlifehappen posted a blog post

    Original story from Breast Cancer Now From: technologynetworks.com A novel drug based on a natural compound found in broccoli, kale and other cruciferous vegetables could hold the key to reversing or even preventing resistance to breast cancer hormone therapy, new research has found. Scientists from the University of Manchester found that drug SFX-01 – which has shown promise in a ...
    The post Novel Drug May Reverse Breast Cancer Hormone Therapy Resistance appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Susan Moench, PhD, PA-C From: oncologynurseadvisor.com Results of a large prospective, longitudinal study showed that receipt of combination systemic therapy including chemotherapy plus trastuzumab was associated with an increased odds of not returning to work 2 years after diagnosis of nonmetastatic breast cancer. The findings from this study were published in the Journal of Clinical Oncology. Although results of ...
    The post Multidimensional Factors Underlying Ability to Work After Primary Treatment for Nonmetastatic Breast Cancer appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    Source: Checkpoint Therapeutics From: checkpointtx.com FDA feedback supports plan to submit Biologics License Application (BLA) based on data from ongoing Phase 1 trial One-third enrollment complete in cohort of patients with metastatic cutaneous squamous cell carcinoma Potential for cosibelimab to be differentiated and lower-cost alternative to available anti-PD-1/L1 mAbs Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted ...
    The post Checkpoint Therapeutics Announces Confirmation of Registration Path for Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Swinburne University of Technology From: medicalxpress.com A new study has found that using a community-codesign approach can massively increase mammography screening rates among Italian and Arabic-speaking women. The study, published in PLOS One, tested simple but novel strategies suggested by women in the community and co-designed by Breast Screen Victoria as part of the OPtimise HEalth LIteracy and Access ...
    The post Initiative helps increase breast cancer screening appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Danielle Ternyila From: targetedonc.com Patients with advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC) can now be treated with the FDA-approved combination of atezolizumab (Tecentriq) plus nab-paclitaxel (Abraxane) in the frontline setting, based on data from the phase III IMpassion130 trial (NCT02425891). According to Elizabeth Mittendorf, MD, PhD, this is a monumental improvement for the treatment of patients with ...
    The post Immunotherapeutic Agents Expand Treatment Landscape for Triple-Negative Breast Cancer appeared first on Let Life Happen.

  • letlifehappen's Avatar

    letlifehappen posted a blog post

    By: Robert King From: fiercehealthcare.com Medicare can now cover breakthrough laboratory diagnostic tests that use Next Generation Sequencing for patients with inherited ovarian or breast cancer. The decision announced Monday by the Centers for Medicare & Medicaid Services is the latest move by the agency to address how to cover costly new cancer diagnostics and treatments. CMS decided to first ...
    The post Payer CMS approves Medicare coverage of next-generation sequencing tests for inherited ovarian, breast cancers appeared first on Let Life Happen.